Key features of hospitals antibiotic stewardship software solutions needed for successfully optimizing patient outcomes while fighting antibiotic resistance on a global scale – a shared experience

Antimicrobial resistance threatens the very core of modern medicine and currently costs the EU more than 11.7 billion euro per year. In 2050 it is projected that 10 million people will die from infections with the so called “superbugs”. In the past few decades, no entirely new antibiotic groups are being discovered which makes of crucial importance to preserve the effectiveness of the antibiotics we have today for future generations. Antimicrobial stewardship programs worldwide aim to optimize the use of antimicrobials to improve effectiveness, safety and economic feasibility of antibiotics while fighting antibiotic resistance on a local and global scale. This article shares the experience of building a software solution from scratch for digitalisation of local antibiotic stewardship policies – what are the key features needed and the steps required for successful implementation of a digital local antibiotic stewardship policy and who are the stakeholders in a project of this nature.

Authors

Institutions

Publication Details

Journal
Pharmacia
Published
2024-08-16
DOI
https://doi.org/10.3897/pharmacia.71.e130414
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Key features of hospitals antibiotic stewardship software solutions needed for successfully optimizing patient outcomes while fighting antibiotic resistance on a global scale – a shared experience

Yavor Assyov, D. Pendicheva-Duhlenska, Andrey Petrov, Emil Gatchev et al.
Pharmacia
Antibiotic Use and Resistance
article

Key features of hospitals antibiotic stewardship software solutions needed for successfully optimizing patient outcomes while fighting antibiotic resistance on a global scale – a shared experience

Yavor Assyov, D. Pendicheva-Duhlenska, Andrey Petrov, Emil Gatchev, Natalia Konova
article en

Abstract

Antimicrobial resistance threatens the very core of modern medicine and currently costs the EU more than 11.7 billion euro per year. In 2050 it is projected that 10 million people will die from infections with the so called “superbugs”. In the past few decades, no entirely new antibiotic groups are being discovered which makes of crucial importance to preserve the effectiveness of the antibiotics we have today for future generations. Antimicrobial stewardship programs worldwide aim to optimize the use of antimicrobials to improve effectiveness, safety and economic feasibility of antibiotics while fighting antibiotic resistance on a local and global scale. This article shares the experience of building a software solution from scratch for digitalisation of local antibiotic stewardship policies – what are the key features needed and the steps required for successful implementation of a digital local antibiotic stewardship policy and who are the stakeholders in a project of this nature.

PharmaciaVol. 71
Alexandrovska Hospital (BG), Queen Giovanna Hospital (BG), Medical University of Sofia (BG), Medical University Pleven (BG)
European Commission
Partnerships for the goals
Openalex Percentile: Top 85%
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Key features of hospitals antibiotic stewardship software solutions needed for successfully optimizing patient outcomes while fighting antibiotic resistance on a global scale – a shared experience — Yavor Assyov, D. Pendicheva-Duhlenska, et al. · Pharmacia (2024) | TGRS Research Map | TGRS